Comparative real-world study of apalutamide and darolutamide in Japanese patients with non-metastatic castration-resistant prostate cancer. Ikeda M, Uemura K, Ito Y, Ito H, et al. BMC Urol 2025;25:235.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Ikeda M, Uemura K, Ito Y, Ito H, et al. Comparative real-world study of apalutamide and darolutamide in Japanese patients with non-metastatic castration-resistant prostate cancer. BMC Urol 2025;25:235.
PMID: 41013513